Sivik Global Healthcare’s Assertio ASRT Stock Holding History

Sivik Global Healthcare’s Portfolio ASRT Stock Details ASRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$1.93M	–	76
2017 Q2	$1.93M	Buy	+3,000	New	+$2M	0.71%	50

Other funds holding ASRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sivik Global Healthcare's ASRT Position: Q3 2017 in Review

Sivik Global Healthcare sold out of Assertio (ASRT) in Q3 2017, closing a stake of 3,000 shares — an estimated $1.93M sold.

Sivik Global Healthcare first reported a position in ASRT in Q2 2017 and held it in 1 quarter. The position peaked at $1.93M in Q2 2017. 165 funds tracked by Wall St. Rank hold ASRT as of Q3 2017.

Sivik Global Healthcare reported no remaining Assertio position as of Q3 2017 after selling out during the quarter.
Sivik Global Healthcare sold 3,000 Assertio shares in Q3 2017, an estimated $1.93M.
Sivik Global Healthcare first reported a position in Assertio in Q2 2017 and held it in 1 quarter.
Sivik Global Healthcare's Assertio position peaked at $1.93M in Q2 2017.
165 funds tracked by Wall St. Rank held Assertio as of Q3 2017.

Based on Sivik Global Healthcare's 13F filing for Q3 2017, filed 8 Nov 2017.